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o date, some 4,000 species of bacteria
have been identified, 200 of which
are pathogenic to humans. Some are
a double-edged sword—in the case of
Escherichia coli, for example, some strains
exist as benign and beneficial occupants of
the human intestinal system, and others
cause potentially life-threatening illnesses.
In the event of a bacterial disease outbreak,
it’s vital for public health officials to know
which strain they’re dealing with as quickly
as possible to be able to track the outbreak’s
source and limit its extent. (Similar knowl-
edge at the clinical level, usually obtained
through a process known as culture and
sensitivity, allows for selection of appropri-
ate antibiotics for treatment, as many bacte-
rial strains have developed a resistance to
some antibiotics.)
A recent analytical advancement at Los
Alamos National Laboratory in New
Mexico may have a great influence on rapid
bacterial strain identification. A group of
Los Alamos scientists led by Richard Keller,
Babetta Marrone, and James Jett has built
upon earlier flow cytometry technology to
create a device that allows public health
officials and others to study bacteria at the
molecular level, differentiating between
individual strains more quickly and with
greater accuracy than was possible before.
In the original flow cytometer, devel-
oped at Los Alamos in the early 1970s, the
substance being tested is broken down into
individual cells, and each cell passes individ-
ually in a continuous flow through a laser
beam,  scattering the light in a characteristic
manner. Dyes bound to different parts of
the cell emit light, or fluoresce, when passed
through the laser.
Sensors within the cytometer measure
several parameters, including “low-angle
forward scatter intensity,” which is approxi-
mately proportional to cell diameter, and
fluorescence intensities at several wavelengths,
which allows for the study of cell compo-
nents such as total DNA per cell, specific
nucleotide sequences, and, by labeling with
monoclonal antibodies, specific cellular pro-
teins and other molecules. Flow cytometers
are now common in hospitals and public
health labs across the country.
A few years ago, the Los Alamos group
began refining the capabilities of the flow
cytometer so that it could analyze not just 
a single cell but a single molecule. This
development makes the term “cytometer”
somewhat of a misnomer, as the new device
deals with molecules rather than cells. 
Flow Chart
“Single molecule detection is the Holy Grail
of analytical chemistry,” Jett says. “In addi-
tion to instrumental developments, one of
the things that helped us . . . was the cre-
ation of a whole new family of DNA-bind-
ing dyes that showed a tremendous leap in
fluorescence when they bonded with DNA.”
The Los Alamos group has used several
different nucleic acid stains, including
PicoGreen, POPO-3, and TOTO-1, all of
which show a 600-fold or larger enhance-
ment in fluorescence when they bind to
DNA. But even with the increased fluores-
cence, relatively little light is emitted when
the individual molecules pass through the
laser beam. So the group slowed the flow
rate from 10 meters per second to 10 mil-
limeters per second, keeping the fragments
and the dye bound to them in the light
source for a longer period so more photons
could be emitted, collected, and measured
using a solid-state photon-counting detector.
As stained DNA fragments are run
through the flow cytometer, they trigger
brief bursts of fluorescence. The size of the
burst is directly proportional to the number
of dye molecules that bind to the DNA and
thus reveals the size of the DNA fragment as
measured in base pairs. These bursts are
recorded, producing a histogram, a DNA
“fingerprint,” which is exactly analogous to
the electrophoretogram produced by gel
electrophoresis. In that technique, DNA-
containing samples are purified, then treated
with enzymes that cut the DNA at specific
points, creating a collection of “clippings”
that is characteristic of the organism 
that produced it. (A later variation of gel 
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is [PFGE], involves alternating an electric
current to move particles toward and away
from a pair of electrodes to increase size-
dependent separation, improving resolution
for larger fragments.) 
In Los Alamos experiments with purified
E. coli and Staphylococcus aureus samples,
DNA histograms were obtained in 10 min-
utes. Both PFGE and flow cytometry require
similar sample preparation times, but even
when sample preparation time was factored
in, increasing the flow cytometry time to 8
hours, it was still faster than the 24 hours
required by PFGE. This is significant even
when one considers that flow cytometry runs
samples one at a time, something unlikely to
happen in a clinical setting, while PFGE can
typically run 15 samples on a single gel. The
Los Alamos flow cytometer yields results
with a much lower uncertainty (2–5% versus
10% for PFGE), is 200,000 times more
sensitive than PFGE, and uses picogram
quantities of DNA, as opposed to the hun-
dreds of nanograms called for in PFGE. And
flow cytometry is far more quantitative than
PFGE because it counts individual fragments
of DNA, whereas PFGE estimates DNA
based on the intensity of the emission from
the dye used to visualize the band.
The Los Alamos team has already devel-
oped the next model of the flow cytometer
using a different DNA-binding dye (SYTOX
Orange) and a smaller laser that runs on a
five-volt power supply, requires neither
water nor forced-air cooling, and emits at
approximately the maximum absorption
wavelength of the dye—the wavelength to
which the dye will be most responsive. A
single data-acquisition card in a computer
constitutes the data collection system. The
laser light is focused on the sample stream
delivered by a piece of silicon capillary 
tubing 30–50 centimeters long and 40
micrometers in interior diameter. A photon-
counting silicon avalanche photodiode
assembly registers the emitted photons.
Using the Flow
The Los Alamos group has patented the new
flow cytometer, and although the patent has
yet to be licensed, Jett says the group is in
discussion with at least three interested
industry groups. Michael Marron, director
of biomedical technology at the National
Center for Research Resources, says the new
flow cytometer shows great promise in a
variety of fields where single molecule study
would be valuable. “The flow cytometer
would be valuable in the study of disease
transmission as well as response to drugs,”
Marron says. “It would also be valuable in
the ongoing study of the human genome, so
we’re looking at something useful in both
patient care and treatment, as well as the
rapid identification of pathogens.” (Part 
of the National Institutes of Health in
Bethesda, Maryland, the National Center
for Research Resources partially funded the
group’s research through the National Flow
Cytometry Resource, a mechanism at Los
Alamos for making state-of-the-art flow
cytometric instrumentation available to the
biomedical research community.) 
Jett adds that the device would also be
useful in responding to a bioterrorist attack.
In such an event, he says, being able to iden-
tify the specific strain of an organism aids in
tracing its origin.
Janet Nicholson, associate director for
laboratory science at the Centers for Disease
Control and Prevention National Center for
Infectious Diseases in Atlanta, Georgia, says,
“This could be a tremendous tool for quickly
identifying the source and type of disease out-
breaks, although it’s a technology still in its
very early stages, with a lot of work still to be
done. Each organism has its own particular
fingerprint in PFGE, which [Jett] has shown
[to be] true in his flow cytometer as well, so
the ability to analyze that fingerprint quickly
and with accuracy would be invaluable. You
could use it to decide if [an outbreak] was a
single-source outbreak or multiple-source; if
it was traced to food processing, you could
decide if a change in the manufacturing
process was needed.”
Nicholson notes that the technology
will have to be cost-effective to be valuable.
“PFGE requires that you incubate and cul-
ture a sample to produce a culture, and many
labs don’t do the culture part in order to save
money,” she says. “When it comes to health,
it shouldn’t be so, but the reality is that any
time a lab selects tests, it’s based on the cost
in labor, reagents, and time. This new flow
cytometer will have to be cost-effective to
the point where it really can be found in any
lab across the country in order to achieve its
full value.”
Jett says the group has found ways to cut
the expense of the device from its current
estimated cost of $35,000. “For example,” he
says, “we used a microscope objective in the
system that cost $3,000, but we’ve since
found an $82 aspheric lens that works just
as well. We also used a $6,000 optical
mounting system, which would probably be
excessive in a commercial system, and we
used a motor controller to move optical
parts, which you probably wouldn’t use in a
commercial system. And our laser cost
$8,000, which commercial production
would probably reduce significantly by
buying in bulk.”
Other issues to be addressed include
how the device will function in a clinical
setting and whether it will require purified
cultures or whether the cytometer can be
programmed to “watch” for specific bacteri-
al indicators within a given sample, search-
ing only for particular biological markers
and excluding other tissue elements such as
red blood cells or nontarget bacteria, which
would be considered contaminants. Says
Jett, “[The device] could require a purified
culture, but we’re also working on second-
color detection, where we can hybridize a
probe to measure not only the length of a
given fragment, but to know that particular
fragments contain particular sequences, and
really refine detection.” (Nicholson believes
much more work is needed to deal with the
complexity of an actual unpurified speci-
men.) The system will also need access to a
large-scale database for rapid comparison of
samples with existing patterns. “I don’t
know how we’ll handle reference linkups,”
Jett admits, referring to this access.
“Perhaps through a direct link [to a data-
base], but we could also have a download-
able database, so a hospital dealing with a
particular strain could trace it among its
patients without relying on the [remote]
database. Those are things we’ll address as
we proceed.” The operation of the system
must also be streamlined and sped up for
commercial use, Jett acknowledges.
But none of these are insurmountable
obstacles, in Jett’s opinion. Furthermore, he
says, given the great value of the system,“I think
it makes these goals well worth pursuing.”
Lance Frazer
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